A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn disease.
Chehade
M
M
Division of Pediatric Gastroenterology, Mount Sinai School of Medicine, New York, New York, USA.
Benkov
K
K
D000293:Adolescent; D000963:Antimetabolites / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003424:Crohn Disease / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D008297:Male; D015122:Mercaptopurine / Q000009:adverse effects / Q000627:therapeutic use*; D015337:Multicenter Studies as Topic; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D000963:Antimetabolites; D005938:Glucocorticoids; D015122:Mercaptopurine; D011241:Prednisone